nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—Bopindolol—Carteolol—glaucoma	0.129	0.31	CrCrCtD
Propafenone—ADRB1—Levobunolol—glaucoma	0.0739	0.174	CbGbCtD
Propafenone—ADRB1—Metipranolol—glaucoma	0.0739	0.174	CbGbCtD
Propafenone—Esmolol—Metipranolol—glaucoma	0.0709	0.17	CrCrCtD
Propafenone—ADRB1—Carteolol—glaucoma	0.0628	0.148	CbGbCtD
Propafenone—Esmolol—Betaxolol—glaucoma	0.0496	0.119	CrCrCtD
Propafenone—Propranolol—Carteolol—glaucoma	0.0462	0.111	CrCrCtD
Propafenone—Propranolol—Levobunolol—glaucoma	0.0462	0.111	CrCrCtD
Propafenone—Propranolol—Metipranolol—glaucoma	0.0441	0.106	CrCrCtD
Propafenone—ADRB1—Betaxolol—glaucoma	0.0424	0.1	CbGbCtD
Propafenone—Propranolol—Betaxolol—glaucoma	0.0308	0.0739	CrCrCtD
Propafenone—ADRB1—Timolol—glaucoma	0.0273	0.0644	CbGbCtD
Propafenone—CYP2D6—Carteolol—glaucoma	0.016	0.0377	CbGbCtD
Propafenone—CYP1A2—Betaxolol—glaucoma	0.0131	0.0309	CbGbCtD
Propafenone—CYP2D6—Betaxolol—glaucoma	0.0108	0.0255	CbGbCtD
Propafenone—CYP2C9—Diclofenamide—glaucoma	0.0104	0.0245	CbGbCtD
Propafenone—CYP2C9—Dorzolamide—glaucoma	0.01	0.0237	CbGbCtD
Propafenone—CYP2C9—Methazolamide—glaucoma	0.00896	0.0211	CbGbCtD
Propafenone—CYP2D6—Methazolamide—glaucoma	0.00819	0.0193	CbGbCtD
Propafenone—CYP3A4—Pilocarpine—glaucoma	0.00771	0.0182	CbGbCtD
Propafenone—ABCB1—Timolol—glaucoma	0.00739	0.0174	CbGbCtD
Propafenone—CYP1A2—Clonidine—glaucoma	0.00719	0.0169	CbGbCtD
Propafenone—CYP2D6—Timolol—glaucoma	0.00696	0.0164	CbGbCtD
Propafenone—ABCB1—Clonidine—glaucoma	0.00628	0.0148	CbGbCtD
Propafenone—CYP3A4—Brinzolamide—glaucoma	0.00605	0.0143	CbGbCtD
Propafenone—CYP2D6—Clonidine—glaucoma	0.00592	0.014	CbGbCtD
Propafenone—CYP3A4—Dorzolamide—glaucoma	0.00584	0.0138	CbGbCtD
Propafenone—CYP3A4—Methazolamide—glaucoma	0.00521	0.0123	CbGbCtD
Propafenone—CYP3A4—Acetazolamide—glaucoma	0.00416	0.00981	CbGbCtD
Propafenone—CYP3A4—Clonidine—glaucoma	0.00376	0.00887	CbGbCtD
Propafenone—Benazepril—MTHFR—glaucoma	0.000435	0.388	CrCbGaD
Propafenone—Carvedilol—VEGFA—glaucoma	0.00033	0.294	CrCbGaD
Propafenone—Oxaprozin—PTGS2—glaucoma	0.000179	0.159	CrCbGaD
Propafenone—Salsalate—PTGS2—glaucoma	0.000179	0.159	CrCbGaD
Propafenone—Feeling abnormal—Dorzolamide—glaucoma	5.9e-05	0.000395	CcSEcCtD
Propafenone—Decreased appetite—Pilocarpine—glaucoma	5.89e-05	0.000393	CcSEcCtD
Propafenone—Feeling abnormal—Travoprost—glaucoma	5.88e-05	0.000393	CcSEcCtD
Propafenone—Gastrointestinal pain—Dorzolamide—glaucoma	5.86e-05	0.000392	CcSEcCtD
Propafenone—Alopecia—Betaxolol—glaucoma	5.86e-05	0.000391	CcSEcCtD
Propafenone—Palpitations—Clonidine—glaucoma	5.85e-05	0.000391	CcSEcCtD
Propafenone—Gastrointestinal disorder—Pilocarpine—glaucoma	5.85e-05	0.000391	CcSEcCtD
Propafenone—Gastrointestinal pain—Travoprost—glaucoma	5.83e-05	0.00039	CcSEcCtD
Propafenone—Loss of consciousness—Clonidine—glaucoma	5.82e-05	0.000389	CcSEcCtD
Propafenone—Feeling abnormal—Brinzolamide—glaucoma	5.81e-05	0.000388	CcSEcCtD
Propafenone—Mental disorder—Betaxolol—glaucoma	5.81e-05	0.000388	CcSEcCtD
Propafenone—Constipation—Pilocarpine—glaucoma	5.79e-05	0.000387	CcSEcCtD
Propafenone—Pain—Pilocarpine—glaucoma	5.79e-05	0.000387	CcSEcCtD
Propafenone—Cough—Clonidine—glaucoma	5.78e-05	0.000386	CcSEcCtD
Propafenone—Dizziness—Apraclonidine—glaucoma	5.78e-05	0.000386	CcSEcCtD
Propafenone—Erythema—Betaxolol—glaucoma	5.77e-05	0.000385	CcSEcCtD
Propafenone—Malnutrition—Betaxolol—glaucoma	5.77e-05	0.000385	CcSEcCtD
Propafenone—Urticaria—Dorzolamide—glaucoma	5.69e-05	0.00038	CcSEcCtD
Propafenone—Epistaxis—Timolol—glaucoma	5.69e-05	0.00038	CcSEcCtD
Propafenone—Abdominal pain—Dorzolamide—glaucoma	5.66e-05	0.000379	CcSEcCtD
Propafenone—Body temperature increased—Dorzolamide—glaucoma	5.66e-05	0.000379	CcSEcCtD
Propafenone—Tension—Betaxolol—glaucoma	5.66e-05	0.000378	CcSEcCtD
Propafenone—Dysgeusia—Betaxolol—glaucoma	5.65e-05	0.000377	CcSEcCtD
Propafenone—Chest pain—Clonidine—glaucoma	5.64e-05	0.000377	CcSEcCtD
Propafenone—Abdominal pain—Travoprost—glaucoma	5.64e-05	0.000377	CcSEcCtD
Propafenone—Agranulocytosis—Timolol—glaucoma	5.63e-05	0.000376	CcSEcCtD
Propafenone—Anxiety—Clonidine—glaucoma	5.62e-05	0.000376	CcSEcCtD
Propafenone—Asthenia—Acetazolamide—glaucoma	5.61e-05	0.000375	CcSEcCtD
Propafenone—Dizziness—Bimatoprost—glaucoma	5.6e-05	0.000374	CcSEcCtD
Propafenone—Nervousness—Betaxolol—glaucoma	5.6e-05	0.000374	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	5.6e-05	0.000374	CcSEcCtD
Propafenone—Urticaria—Brinzolamide—glaucoma	5.6e-05	0.000374	CcSEcCtD
Propafenone—Feeling abnormal—Pilocarpine—glaucoma	5.58e-05	0.000373	CcSEcCtD
Propafenone—Discomfort—Clonidine—glaucoma	5.57e-05	0.000372	CcSEcCtD
Propafenone—Vomiting—Apraclonidine—glaucoma	5.56e-05	0.000371	CcSEcCtD
Propafenone—Muscle spasms—Betaxolol—glaucoma	5.55e-05	0.000371	CcSEcCtD
Propafenone—Gastrointestinal pain—Pilocarpine—glaucoma	5.54e-05	0.00037	CcSEcCtD
Propafenone—Hypersensitivity—Brimonidine—glaucoma	5.53e-05	0.000369	CcSEcCtD
Propafenone—Dry mouth—Clonidine—glaucoma	5.52e-05	0.000369	CcSEcCtD
Propafenone—Bradycardia—Timolol—glaucoma	5.51e-05	0.000368	CcSEcCtD
Propafenone—Dermatitis—Apraclonidine—glaucoma	5.51e-05	0.000368	CcSEcCtD
Propafenone—Headache—Apraclonidine—glaucoma	5.48e-05	0.000366	CcSEcCtD
Propafenone—Confusional state—Clonidine—glaucoma	5.45e-05	0.000364	CcSEcCtD
Propafenone—Vision blurred—Betaxolol—glaucoma	5.44e-05	0.000363	CcSEcCtD
Propafenone—Rhinitis—Timolol—glaucoma	5.43e-05	0.000363	CcSEcCtD
Propafenone—Oedema—Clonidine—glaucoma	5.41e-05	0.000361	CcSEcCtD
Propafenone—Tremor—Betaxolol—glaucoma	5.4e-05	0.000361	CcSEcCtD
Propafenone—Asthenia—Brimonidine—glaucoma	5.38e-05	0.00036	CcSEcCtD
Propafenone—Infection—Clonidine—glaucoma	5.37e-05	0.000359	CcSEcCtD
Propafenone—Body temperature increased—Pilocarpine—glaucoma	5.35e-05	0.000358	CcSEcCtD
Propafenone—Abdominal pain—Pilocarpine—glaucoma	5.35e-05	0.000358	CcSEcCtD
Propafenone—Ill-defined disorder—Betaxolol—glaucoma	5.35e-05	0.000358	CcSEcCtD
Propafenone—Diarrhoea—Acetazolamide—glaucoma	5.35e-05	0.000357	CcSEcCtD
Propafenone—Rash—Bimatoprost—glaucoma	5.34e-05	0.000357	CcSEcCtD
Propafenone—Dermatitis—Bimatoprost—glaucoma	5.34e-05	0.000357	CcSEcCtD
Propafenone—Anaemia—Betaxolol—glaucoma	5.33e-05	0.000356	CcSEcCtD
Propafenone—Shock—Clonidine—glaucoma	5.32e-05	0.000356	CcSEcCtD
Propafenone—Connective tissue disorder—Timolol—glaucoma	5.32e-05	0.000355	CcSEcCtD
Propafenone—Pruritus—Brimonidine—glaucoma	5.31e-05	0.000355	CcSEcCtD
Propafenone—Headache—Bimatoprost—glaucoma	5.31e-05	0.000355	CcSEcCtD
Propafenone—Nervous system disorder—Clonidine—glaucoma	5.3e-05	0.000354	CcSEcCtD
Propafenone—Thrombocytopenia—Clonidine—glaucoma	5.29e-05	0.000354	CcSEcCtD
Propafenone—Hypersensitivity—Dorzolamide—glaucoma	5.28e-05	0.000353	CcSEcCtD
Propafenone—Tachycardia—Clonidine—glaucoma	5.28e-05	0.000353	CcSEcCtD
Propafenone—Hypersensitivity—Travoprost—glaucoma	5.26e-05	0.000351	CcSEcCtD
Propafenone—Skin disorder—Clonidine—glaucoma	5.25e-05	0.000351	CcSEcCtD
Propafenone—Hyperhidrosis—Clonidine—glaucoma	5.23e-05	0.000349	CcSEcCtD
Propafenone—Visual impairment—Timolol—glaucoma	5.22e-05	0.000349	CcSEcCtD
Propafenone—Malaise—Betaxolol—glaucoma	5.2e-05	0.000348	CcSEcCtD
Propafenone—Nausea—Apraclonidine—glaucoma	5.19e-05	0.000347	CcSEcCtD
Propafenone—Hypersensitivity—Brinzolamide—glaucoma	5.19e-05	0.000347	CcSEcCtD
Propafenone—Vertigo—Betaxolol—glaucoma	5.18e-05	0.000346	CcSEcCtD
Propafenone—Syncope—Betaxolol—glaucoma	5.17e-05	0.000346	CcSEcCtD
Propafenone—Dizziness—Acetazolamide—glaucoma	5.17e-05	0.000345	CcSEcCtD
Propafenone—Anorexia—Clonidine—glaucoma	5.15e-05	0.000344	CcSEcCtD
Propafenone—Asthenia—Dorzolamide—glaucoma	5.14e-05	0.000344	CcSEcCtD
Propafenone—Asthenia—Travoprost—glaucoma	5.12e-05	0.000342	CcSEcCtD
Propafenone—Palpitations—Betaxolol—glaucoma	5.1e-05	0.000341	CcSEcCtD
Propafenone—Pruritus—Dorzolamide—glaucoma	5.07e-05	0.000339	CcSEcCtD
Propafenone—Loss of consciousness—Betaxolol—glaucoma	5.07e-05	0.000339	CcSEcCtD
Propafenone—Eye disorder—Timolol—glaucoma	5.06e-05	0.000338	CcSEcCtD
Propafenone—Asthenia—Brinzolamide—glaucoma	5.05e-05	0.000338	CcSEcCtD
Propafenone—Hypotension—Clonidine—glaucoma	5.05e-05	0.000338	CcSEcCtD
Propafenone—Pruritus—Travoprost—glaucoma	5.05e-05	0.000337	CcSEcCtD
Propafenone—Tinnitus—Timolol—glaucoma	5.05e-05	0.000337	CcSEcCtD
Propafenone—Cough—Betaxolol—glaucoma	5.03e-05	0.000336	CcSEcCtD
Propafenone—Nausea—Bimatoprost—glaucoma	5.03e-05	0.000336	CcSEcCtD
Propafenone—Cardiac disorder—Timolol—glaucoma	5.02e-05	0.000336	CcSEcCtD
Propafenone—Hypersensitivity—Pilocarpine—glaucoma	4.99e-05	0.000333	CcSEcCtD
Propafenone—Pruritus—Brinzolamide—glaucoma	4.98e-05	0.000333	CcSEcCtD
Propafenone—Vomiting—Acetazolamide—glaucoma	4.97e-05	0.000332	CcSEcCtD
Propafenone—Dizziness—Brimonidine—glaucoma	4.96e-05	0.000332	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Clonidine—glaucoma	4.93e-05	0.000329	CcSEcCtD
Propafenone—Angiopathy—Timolol—glaucoma	4.91e-05	0.000328	CcSEcCtD
Propafenone—Myalgia—Betaxolol—glaucoma	4.91e-05	0.000328	CcSEcCtD
Propafenone—Chest pain—Betaxolol—glaucoma	4.91e-05	0.000328	CcSEcCtD
Propafenone—Diarrhoea—Dorzolamide—glaucoma	4.9e-05	0.000328	CcSEcCtD
Propafenone—Headache—Acetazolamide—glaucoma	4.9e-05	0.000327	CcSEcCtD
Propafenone—Anxiety—Betaxolol—glaucoma	4.89e-05	0.000327	CcSEcCtD
Propafenone—Insomnia—Clonidine—glaucoma	4.89e-05	0.000327	CcSEcCtD
Propafenone—Immune system disorder—Timolol—glaucoma	4.89e-05	0.000327	CcSEcCtD
Propafenone—Diarrhoea—Travoprost—glaucoma	4.88e-05	0.000326	CcSEcCtD
Propafenone—Mediastinal disorder—Timolol—glaucoma	4.88e-05	0.000326	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	4.88e-05	0.000326	CcSEcCtD
Propafenone—Asthenia—Pilocarpine—glaucoma	4.86e-05	0.000325	CcSEcCtD
Propafenone—Paraesthesia—Clonidine—glaucoma	4.86e-05	0.000324	CcSEcCtD
Propafenone—Discomfort—Betaxolol—glaucoma	4.85e-05	0.000324	CcSEcCtD
Propafenone—Arrhythmia—Timolol—glaucoma	4.84e-05	0.000323	CcSEcCtD
Propafenone—Dyspnoea—Clonidine—glaucoma	4.82e-05	0.000322	CcSEcCtD
Propafenone—Diarrhoea—Brinzolamide—glaucoma	4.82e-05	0.000322	CcSEcCtD
Propafenone—Somnolence—Clonidine—glaucoma	4.81e-05	0.000321	CcSEcCtD
Propafenone—Dry mouth—Betaxolol—glaucoma	4.8e-05	0.000321	CcSEcCtD
Propafenone—Pruritus—Pilocarpine—glaucoma	4.79e-05	0.00032	CcSEcCtD
Propafenone—Alopecia—Timolol—glaucoma	4.78e-05	0.00032	CcSEcCtD
Propafenone—Confusional state—Betaxolol—glaucoma	4.75e-05	0.000317	CcSEcCtD
Propafenone—Mental disorder—Timolol—glaucoma	4.74e-05	0.000317	CcSEcCtD
Propafenone—Dizziness—Dorzolamide—glaucoma	4.74e-05	0.000317	CcSEcCtD
Propafenone—Rash—Brimonidine—glaucoma	4.73e-05	0.000316	CcSEcCtD
Propafenone—Dermatitis—Brimonidine—glaucoma	4.73e-05	0.000316	CcSEcCtD
Propafenone—Dizziness—Travoprost—glaucoma	4.72e-05	0.000315	CcSEcCtD
Propafenone—Malnutrition—Timolol—glaucoma	4.71e-05	0.000315	CcSEcCtD
Propafenone—Erythema—Timolol—glaucoma	4.71e-05	0.000315	CcSEcCtD
Propafenone—Oedema—Betaxolol—glaucoma	4.71e-05	0.000315	CcSEcCtD
Propafenone—Headache—Brimonidine—glaucoma	4.7e-05	0.000314	CcSEcCtD
Propafenone—Decreased appetite—Clonidine—glaucoma	4.7e-05	0.000314	CcSEcCtD
Propafenone—Infection—Betaxolol—glaucoma	4.68e-05	0.000313	CcSEcCtD
Propafenone—Gastrointestinal disorder—Clonidine—glaucoma	4.67e-05	0.000312	CcSEcCtD
Propafenone—Fatigue—Clonidine—glaucoma	4.66e-05	0.000312	CcSEcCtD
Propafenone—Dizziness—Brinzolamide—glaucoma	4.66e-05	0.000311	CcSEcCtD
Propafenone—Nausea—Acetazolamide—glaucoma	4.64e-05	0.00031	CcSEcCtD
Propafenone—Diarrhoea—Pilocarpine—glaucoma	4.63e-05	0.00031	CcSEcCtD
Propafenone—Shock—Betaxolol—glaucoma	4.63e-05	0.00031	CcSEcCtD
Propafenone—Tension—Timolol—glaucoma	4.62e-05	0.000309	CcSEcCtD
Propafenone—Pain—Clonidine—glaucoma	4.62e-05	0.000309	CcSEcCtD
Propafenone—Constipation—Clonidine—glaucoma	4.62e-05	0.000309	CcSEcCtD
Propafenone—Nervous system disorder—Betaxolol—glaucoma	4.62e-05	0.000309	CcSEcCtD
Propafenone—Dysgeusia—Timolol—glaucoma	4.61e-05	0.000308	CcSEcCtD
Propafenone—Thrombocytopenia—Betaxolol—glaucoma	4.61e-05	0.000308	CcSEcCtD
Propafenone—Tachycardia—Betaxolol—glaucoma	4.59e-05	0.000307	CcSEcCtD
Propafenone—Nervousness—Timolol—glaucoma	4.58e-05	0.000306	CcSEcCtD
Propafenone—Skin disorder—Betaxolol—glaucoma	4.57e-05	0.000306	CcSEcCtD
Propafenone—Vomiting—Dorzolamide—glaucoma	4.56e-05	0.000304	CcSEcCtD
Propafenone—Hyperhidrosis—Betaxolol—glaucoma	4.55e-05	0.000304	CcSEcCtD
Propafenone—Rash—Dorzolamide—glaucoma	4.52e-05	0.000302	CcSEcCtD
Propafenone—Dermatitis—Dorzolamide—glaucoma	4.51e-05	0.000302	CcSEcCtD
Propafenone—Rash—Travoprost—glaucoma	4.5e-05	0.000301	CcSEcCtD
Propafenone—Dermatitis—Travoprost—glaucoma	4.49e-05	0.0003	CcSEcCtD
Propafenone—Headache—Dorzolamide—glaucoma	4.49e-05	0.0003	CcSEcCtD
Propafenone—Anorexia—Betaxolol—glaucoma	4.49e-05	0.0003	CcSEcCtD
Propafenone—Vomiting—Brinzolamide—glaucoma	4.48e-05	0.000299	CcSEcCtD
Propafenone—Dizziness—Pilocarpine—glaucoma	4.48e-05	0.000299	CcSEcCtD
Propafenone—Headache—Travoprost—glaucoma	4.47e-05	0.000299	CcSEcCtD
Propafenone—Nausea—Brimonidine—glaucoma	4.46e-05	0.000298	CcSEcCtD
Propafenone—Feeling abnormal—Clonidine—glaucoma	4.46e-05	0.000298	CcSEcCtD
Propafenone—Rash—Brinzolamide—glaucoma	4.44e-05	0.000297	CcSEcCtD
Propafenone—Vision blurred—Timolol—glaucoma	4.44e-05	0.000297	CcSEcCtD
Propafenone—Dermatitis—Brinzolamide—glaucoma	4.44e-05	0.000297	CcSEcCtD
Propafenone—Gastrointestinal pain—Clonidine—glaucoma	4.42e-05	0.000295	CcSEcCtD
Propafenone—Headache—Brinzolamide—glaucoma	4.41e-05	0.000295	CcSEcCtD
Propafenone—Hypotension—Betaxolol—glaucoma	4.4e-05	0.000294	CcSEcCtD
Propafenone—Vomiting—Pilocarpine—glaucoma	4.31e-05	0.000288	CcSEcCtD
Propafenone—Urticaria—Clonidine—glaucoma	4.3e-05	0.000287	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Betaxolol—glaucoma	4.29e-05	0.000287	CcSEcCtD
Propafenone—Abdominal pain—Clonidine—glaucoma	4.27e-05	0.000286	CcSEcCtD
Propafenone—Body temperature increased—Clonidine—glaucoma	4.27e-05	0.000286	CcSEcCtD
Propafenone—Rash—Pilocarpine—glaucoma	4.27e-05	0.000285	CcSEcCtD
Propafenone—Dermatitis—Pilocarpine—glaucoma	4.27e-05	0.000285	CcSEcCtD
Propafenone—Insomnia—Betaxolol—glaucoma	4.26e-05	0.000285	CcSEcCtD
Propafenone—Nausea—Dorzolamide—glaucoma	4.26e-05	0.000284	CcSEcCtD
Propafenone—Headache—Pilocarpine—glaucoma	4.24e-05	0.000283	CcSEcCtD
Propafenone—Nausea—Travoprost—glaucoma	4.24e-05	0.000283	CcSEcCtD
Propafenone—Vertigo—Timolol—glaucoma	4.23e-05	0.000283	CcSEcCtD
Propafenone—Paraesthesia—Betaxolol—glaucoma	4.23e-05	0.000283	CcSEcCtD
Propafenone—Syncope—Timolol—glaucoma	4.23e-05	0.000282	CcSEcCtD
Propafenone—Dyspnoea—Betaxolol—glaucoma	4.2e-05	0.00028	CcSEcCtD
Propafenone—Nausea—Brinzolamide—glaucoma	4.18e-05	0.00028	CcSEcCtD
Propafenone—Palpitations—Timolol—glaucoma	4.16e-05	0.000278	CcSEcCtD
Propafenone—Dyspepsia—Betaxolol—glaucoma	4.14e-05	0.000277	CcSEcCtD
Propafenone—Loss of consciousness—Timolol—glaucoma	4.14e-05	0.000277	CcSEcCtD
Propafenone—Cough—Timolol—glaucoma	4.11e-05	0.000275	CcSEcCtD
Propafenone—Decreased appetite—Betaxolol—glaucoma	4.09e-05	0.000273	CcSEcCtD
Propafenone—Hypertension—Timolol—glaucoma	4.07e-05	0.000272	CcSEcCtD
Propafenone—Gastrointestinal disorder—Betaxolol—glaucoma	4.06e-05	0.000272	CcSEcCtD
Propafenone—Fatigue—Betaxolol—glaucoma	4.06e-05	0.000271	CcSEcCtD
Propafenone—Pain—Betaxolol—glaucoma	4.03e-05	0.000269	CcSEcCtD
Propafenone—Constipation—Betaxolol—glaucoma	4.03e-05	0.000269	CcSEcCtD
Propafenone—Nausea—Pilocarpine—glaucoma	4.02e-05	0.000269	CcSEcCtD
Propafenone—Chest pain—Timolol—glaucoma	4.01e-05	0.000268	CcSEcCtD
Propafenone—Myalgia—Timolol—glaucoma	4.01e-05	0.000268	CcSEcCtD
Propafenone—Anxiety—Timolol—glaucoma	4e-05	0.000267	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	3.98e-05	0.000266	CcSEcCtD
Propafenone—Hypersensitivity—Clonidine—glaucoma	3.98e-05	0.000266	CcSEcCtD
Propafenone—KCNH2—SIDS Susceptibility Pathways—BDNF—glaucoma	3.97e-05	0.00518	CbGpPWpGaD
Propafenone—Discomfort—Timolol—glaucoma	3.96e-05	0.000265	CcSEcCtD
Propafenone—SCN5A—SIDS Susceptibility Pathways—IL1A—glaucoma	3.93e-05	0.00513	CbGpPWpGaD
Propafenone—CYP2C8—Oxidation by Cytochrome P450—CYP1B1—glaucoma	3.93e-05	0.00513	CbGpPWpGaD
Propafenone—Dry mouth—Timolol—glaucoma	3.92e-05	0.000262	CcSEcCtD
Propafenone—Asthenia—Clonidine—glaucoma	3.88e-05	0.000259	CcSEcCtD
Propafenone—Feeling abnormal—Betaxolol—glaucoma	3.88e-05	0.000259	CcSEcCtD
Propafenone—Confusional state—Timolol—glaucoma	3.88e-05	0.000259	CcSEcCtD
Propafenone—Oedema—Timolol—glaucoma	3.85e-05	0.000257	CcSEcCtD
Propafenone—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	3.85e-05	0.00502	CbGpPWpGaD
Propafenone—Pruritus—Clonidine—glaucoma	3.83e-05	0.000256	CcSEcCtD
Propafenone—Infection—Timolol—glaucoma	3.82e-05	0.000255	CcSEcCtD
Propafenone—KCNH2—SIDS Susceptibility Pathways—IL1A—glaucoma	3.81e-05	0.00497	CbGpPWpGaD
Propafenone—Shock—Timolol—glaucoma	3.78e-05	0.000253	CcSEcCtD
Propafenone—Nervous system disorder—Timolol—glaucoma	3.77e-05	0.000252	CcSEcCtD
Propafenone—CYP2C9—Arachidonic acid metabolism—CYP1B1—glaucoma	3.75e-05	0.0049	CbGpPWpGaD
Propafenone—Urticaria—Betaxolol—glaucoma	3.74e-05	0.00025	CcSEcCtD
Propafenone—Skin disorder—Timolol—glaucoma	3.74e-05	0.00025	CcSEcCtD
Propafenone—Body temperature increased—Betaxolol—glaucoma	3.72e-05	0.000249	CcSEcCtD
Propafenone—Hyperhidrosis—Timolol—glaucoma	3.72e-05	0.000248	CcSEcCtD
Propafenone—Diarrhoea—Clonidine—glaucoma	3.7e-05	0.000247	CcSEcCtD
Propafenone—Anorexia—Timolol—glaucoma	3.67e-05	0.000245	CcSEcCtD
Propafenone—ADRB1—GPCR ligand binding—OPN4—glaucoma	3.66e-05	0.00478	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—NGF—glaucoma	3.63e-05	0.00474	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—NR3C1—glaucoma	3.61e-05	0.00472	CbGpPWpGaD
Propafenone—Hypotension—Timolol—glaucoma	3.59e-05	0.00024	CcSEcCtD
Propafenone—SCN5A—Developmental Biology—NCK2—glaucoma	3.58e-05	0.00468	CbGpPWpGaD
Propafenone—Dizziness—Clonidine—glaucoma	3.58e-05	0.000239	CcSEcCtD
Propafenone—KCNH2—SIDS Susceptibility Pathways—NGF—glaucoma	3.52e-05	0.0046	CbGpPWpGaD
Propafenone—Musculoskeletal discomfort—Timolol—glaucoma	3.5e-05	0.000234	CcSEcCtD
Propafenone—KCNH2—SIDS Susceptibility Pathways—NR3C1—glaucoma	3.5e-05	0.00458	CbGpPWpGaD
Propafenone—Insomnia—Timolol—glaucoma	3.48e-05	0.000232	CcSEcCtD
Propafenone—Hypersensitivity—Betaxolol—glaucoma	3.47e-05	0.000232	CcSEcCtD
Propafenone—Paraesthesia—Timolol—glaucoma	3.45e-05	0.000231	CcSEcCtD
Propafenone—Vomiting—Clonidine—glaucoma	3.44e-05	0.00023	CcSEcCtD
Propafenone—Dyspnoea—Timolol—glaucoma	3.43e-05	0.000229	CcSEcCtD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	3.42e-05	0.00447	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	3.42e-05	0.00447	CbGpPWpGaD
Propafenone—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	3.42e-05	0.00447	CbGpPWpGaD
Propafenone—Somnolence—Timolol—glaucoma	3.42e-05	0.000228	CcSEcCtD
Propafenone—Rash—Clonidine—glaucoma	3.41e-05	0.000228	CcSEcCtD
Propafenone—Dermatitis—Clonidine—glaucoma	3.41e-05	0.000228	CcSEcCtD
Propafenone—Headache—Clonidine—glaucoma	3.39e-05	0.000226	CcSEcCtD
Propafenone—Dyspepsia—Timolol—glaucoma	3.39e-05	0.000226	CcSEcCtD
Propafenone—Asthenia—Betaxolol—glaucoma	3.38e-05	0.000226	CcSEcCtD
Propafenone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	3.37e-05	0.0044	CbGpPWpGaD
Propafenone—Decreased appetite—Timolol—glaucoma	3.34e-05	0.000223	CcSEcCtD
Propafenone—Pruritus—Betaxolol—glaucoma	3.33e-05	0.000223	CcSEcCtD
Propafenone—Gastrointestinal disorder—Timolol—glaucoma	3.32e-05	0.000222	CcSEcCtD
Propafenone—Fatigue—Timolol—glaucoma	3.32e-05	0.000222	CcSEcCtD
Propafenone—ADRB1—GPCR ligand binding—PTGFR—glaucoma	3.3e-05	0.00431	CbGpPWpGaD
Propafenone—Pain—Timolol—glaucoma	3.29e-05	0.00022	CcSEcCtD
Propafenone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	3.27e-05	0.00427	CbGpPWpGaD
Propafenone—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	3.26e-05	0.00426	CbGpPWpGaD
Propafenone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	3.24e-05	0.00423	CbGpPWpGaD
Propafenone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	3.23e-05	0.00422	CbGpPWpGaD
Propafenone—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	3.23e-05	0.00421	CbGpPWpGaD
Propafenone—Diarrhoea—Betaxolol—glaucoma	3.22e-05	0.000215	CcSEcCtD
Propafenone—Nausea—Clonidine—glaucoma	3.21e-05	0.000215	CcSEcCtD
Propafenone—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	3.2e-05	0.00418	CbGpPWpGaD
Propafenone—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—glaucoma	3.2e-05	0.00418	CbGpPWpGaD
Propafenone—Feeling abnormal—Timolol—glaucoma	3.17e-05	0.000212	CcSEcCtD
Propafenone—Gastrointestinal pain—Timolol—glaucoma	3.14e-05	0.00021	CcSEcCtD
Propafenone—Dizziness—Betaxolol—glaucoma	3.11e-05	0.000208	CcSEcCtD
Propafenone—Urticaria—Timolol—glaucoma	3.06e-05	0.000204	CcSEcCtD
Propafenone—Body temperature increased—Timolol—glaucoma	3.04e-05	0.000203	CcSEcCtD
Propafenone—Abdominal pain—Timolol—glaucoma	3.04e-05	0.000203	CcSEcCtD
Propafenone—Vomiting—Betaxolol—glaucoma	2.99e-05	0.0002	CcSEcCtD
Propafenone—Rash—Betaxolol—glaucoma	2.97e-05	0.000198	CcSEcCtD
Propafenone—Dermatitis—Betaxolol—glaucoma	2.97e-05	0.000198	CcSEcCtD
Propafenone—Headache—Betaxolol—glaucoma	2.95e-05	0.000197	CcSEcCtD
Propafenone—Hypersensitivity—Timolol—glaucoma	2.83e-05	0.000189	CcSEcCtD
Propafenone—Nausea—Betaxolol—glaucoma	2.8e-05	0.000187	CcSEcCtD
Propafenone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	2.77e-05	0.00362	CbGpPWpGaD
Propafenone—Asthenia—Timolol—glaucoma	2.76e-05	0.000184	CcSEcCtD
Propafenone—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	2.73e-05	0.00357	CbGpPWpGaD
Propafenone—Pruritus—Timolol—glaucoma	2.72e-05	0.000182	CcSEcCtD
Propafenone—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	2.65e-05	0.00346	CbGpPWpGaD
Propafenone—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	2.64e-05	0.00345	CbGpPWpGaD
Propafenone—Diarrhoea—Timolol—glaucoma	2.63e-05	0.000176	CcSEcCtD
Propafenone—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	2.63e-05	0.00343	CbGpPWpGaD
Propafenone—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	2.6e-05	0.00339	CbGpPWpGaD
Propafenone—CYP1A2—Phase II conjugation—GSTT1—glaucoma	2.56e-05	0.00334	CbGpPWpGaD
Propafenone—Dizziness—Timolol—glaucoma	2.54e-05	0.00017	CcSEcCtD
Propafenone—Vomiting—Timolol—glaucoma	2.45e-05	0.000163	CcSEcCtD
Propafenone—Rash—Timolol—glaucoma	2.42e-05	0.000162	CcSEcCtD
Propafenone—Dermatitis—Timolol—glaucoma	2.42e-05	0.000162	CcSEcCtD
Propafenone—Headache—Timolol—glaucoma	2.41e-05	0.000161	CcSEcCtD
Propafenone—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	2.38e-05	0.00312	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—PAX6—glaucoma	2.32e-05	0.00303	CbGpPWpGaD
Propafenone—Nausea—Timolol—glaucoma	2.28e-05	0.000153	CcSEcCtD
Propafenone—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	2.24e-05	0.00293	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—IL1A—glaucoma	2.24e-05	0.00292	CbGpPWpGaD
Propafenone—CYP2C8—Biological oxidations—GSTT1—glaucoma	2.15e-05	0.00281	CbGpPWpGaD
Propafenone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	2.14e-05	0.00279	CbGpPWpGaD
Propafenone—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	2.11e-05	0.00275	CbGpPWpGaD
Propafenone—CYP2C8—Arachidonic acid metabolism—PTGS2—glaucoma	2.08e-05	0.00271	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—OPN4—glaucoma	2.07e-05	0.0027	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—FAS—glaucoma	1.99e-05	0.00261	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—C3—glaucoma	1.97e-05	0.00257	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—OPN4—glaucoma	1.88e-05	0.00245	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—PTGFR—glaucoma	1.86e-05	0.00243	CbGpPWpGaD
Propafenone—CYP2D6—Biological oxidations—GSTT1—glaucoma	1.77e-05	0.00231	CbGpPWpGaD
Propafenone—CYP2C9—Biological oxidations—GSTT1—glaucoma	1.75e-05	0.00229	CbGpPWpGaD
Propafenone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	1.74e-05	0.00227	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—VEGFA—glaucoma	1.73e-05	0.00227	CbGpPWpGaD
Propafenone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	1.73e-05	0.00226	CbGpPWpGaD
Propafenone—CYP2C8—Biological oxidations—CYP1B1—glaucoma	1.71e-05	0.00224	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—PTGFR—glaucoma	1.69e-05	0.00221	CbGpPWpGaD
Propafenone—CYP2C8—Metapathway biotransformation—CYP1B1—glaucoma	1.69e-05	0.00221	CbGpPWpGaD
Propafenone—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	1.69e-05	0.00221	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	1.68e-05	0.0022	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—VEGFA—glaucoma	1.68e-05	0.0022	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—SMO—glaucoma	1.66e-05	0.00217	CbGpPWpGaD
Propafenone—CYP1A2—Phase II conjugation—GSTM1—glaucoma	1.63e-05	0.00213	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	1.61e-05	0.0021	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—CTSA—glaucoma	1.6e-05	0.00209	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—LRP12—glaucoma	1.6e-05	0.00209	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	1.54e-05	0.00202	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CA5A—glaucoma	1.51e-05	0.00197	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—NARFL—glaucoma	1.51e-05	0.00197	CbGpPWpGaD
Propafenone—CYP1A2—Biological oxidations—GSTT1—glaucoma	1.5e-05	0.00195	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—TNF—glaucoma	1.49e-05	0.00194	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	1.46e-05	0.00191	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	1.46e-05	0.00191	CbGpPWpGaD
Propafenone—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	1.44e-05	0.00189	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—TNF—glaucoma	1.44e-05	0.00188	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.44e-05	0.00188	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—MMP2—glaucoma	1.43e-05	0.00187	CbGpPWpGaD
Propafenone—CYP2D6—Biological oxidations—CYP1B1—glaucoma	1.41e-05	0.00184	CbGpPWpGaD
Propafenone—CYP2C9—Biological oxidations—CYP1B1—glaucoma	1.4e-05	0.00182	CbGpPWpGaD
Propafenone—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	1.39e-05	0.00181	CbGpPWpGaD
Propafenone—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	1.38e-05	0.0018	CbGpPWpGaD
Propafenone—CYP2C8—Biological oxidations—GSTM1—glaucoma	1.37e-05	0.00179	CbGpPWpGaD
Propafenone—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	1.35e-05	0.00177	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CA5A—glaucoma	1.31e-05	0.00172	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—NARFL—glaucoma	1.31e-05	0.00172	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	1.3e-05	0.0017	CbGpPWpGaD
Propafenone—ADRB1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.26e-05	0.00164	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	1.26e-05	0.00164	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CA5A—glaucoma	1.24e-05	0.00162	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—NARFL—glaucoma	1.24e-05	0.00162	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CA5A—glaucoma	1.23e-05	0.0016	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—NARFL—glaucoma	1.23e-05	0.0016	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	1.22e-05	0.00159	CbGpPWpGaD
Propafenone—CYP1A2—Biological oxidations—CYP1B1—glaucoma	1.19e-05	0.00156	CbGpPWpGaD
Propafenone—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	1.18e-05	0.00154	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	1.16e-05	0.00151	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—GSTT1—glaucoma	1.15e-05	0.00151	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	1.15e-05	0.0015	CbGpPWpGaD
Propafenone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	1.14e-05	0.00149	CbGpPWpGaD
Propafenone—CYP2D6—Biological oxidations—GSTM1—glaucoma	1.13e-05	0.00147	CbGpPWpGaD
Propafenone—CYP2C9—Biological oxidations—GSTM1—glaucoma	1.12e-05	0.00146	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	1.11e-05	0.00145	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—OPN4—glaucoma	1.11e-05	0.00145	CbGpPWpGaD
Propafenone—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	1.11e-05	0.00145	CbGpPWpGaD
Propafenone—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	1.1e-05	0.00144	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—EDN1—glaucoma	1.1e-05	0.00143	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—MMP9—glaucoma	1.08e-05	0.00141	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	1.07e-05	0.0014	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NARFL—glaucoma	1.05e-05	0.00137	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CA5A—glaucoma	1.05e-05	0.00137	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	1.04e-05	0.00136	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	1.04e-05	0.00136	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HEYL—glaucoma	1.03e-05	0.00135	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—MMP2—glaucoma	1.02e-05	0.00134	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PTGFR—glaucoma	9.99e-06	0.00131	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—VEGFA—glaucoma	9.88e-06	0.00129	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	9.84e-06	0.00129	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—VEGFA—glaucoma	9.67e-06	0.00126	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—C3—glaucoma	9.57e-06	0.00125	CbGpPWpGaD
Propafenone—CYP1A2—Biological oxidations—GSTM1—glaucoma	9.53e-06	0.00124	CbGpPWpGaD
Propafenone—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	9.4e-06	0.00123	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—CYP1B1—glaucoma	9.2e-06	0.0012	CbGpPWpGaD
Propafenone—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	9.07e-06	0.00119	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—SMO—glaucoma	8.53e-06	0.00111	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—TNF—glaucoma	8.47e-06	0.00111	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	8.42e-06	0.0011	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CA5A—glaucoma	8.09e-06	0.00106	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NARFL—glaucoma	8.09e-06	0.00106	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	7.87e-06	0.00103	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—RPTOR—glaucoma	7.82e-06	0.00102	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—MMP9—glaucoma	7.68e-06	0.001	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NCK2—glaucoma	7.57e-06	0.000989	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CA1—glaucoma	7.36e-06	0.000962	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—GSTM1—glaucoma	7.36e-06	0.000961	CbGpPWpGaD
Propafenone—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	7.25e-06	0.000948	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CTSA—glaucoma	7.13e-06	0.000932	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—VEGFA—glaucoma	6.9e-06	0.000901	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CA2—glaucoma	6.73e-06	0.00088	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.58e-06	0.00086	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.58e-06	0.00086	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HDAC9—glaucoma	6.44e-06	0.000841	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CA1—glaucoma	6.42e-06	0.000838	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CTSA—glaucoma	6.21e-06	0.000812	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—EDN1—glaucoma	6.19e-06	0.000809	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	6.19e-06	0.000808	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CA1—glaucoma	6.05e-06	0.00079	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CA1—glaucoma	5.99e-06	0.000783	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—TNF—glaucoma	5.91e-06	0.000772	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CA2—glaucoma	5.87e-06	0.000766	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	5.86e-06	0.000766	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CTSA—glaucoma	5.85e-06	0.000765	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CTSA—glaucoma	5.8e-06	0.000758	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—EDN1—glaucoma	5.62e-06	0.000735	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CA2—glaucoma	5.53e-06	0.000722	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CA2—glaucoma	5.48e-06	0.000716	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—C3—glaucoma	5.41e-06	0.000707	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	5.36e-06	0.0007	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	5.36e-06	0.0007	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CA1—glaucoma	5.12e-06	0.000669	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SMO—glaucoma	5.04e-06	0.000658	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CTSA—glaucoma	4.96e-06	0.000648	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—C3—glaucoma	4.91e-06	0.000642	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	4.88e-06	0.000637	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—TXN—glaucoma	4.74e-06	0.00062	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CA2—glaucoma	4.68e-06	0.000612	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NTRK2—glaucoma	4.61e-06	0.000602	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.58e-06	0.000598	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.58e-06	0.000598	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.33e-06	0.000566	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.29e-06	0.00056	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	4.18e-06	0.000546	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—TXN—glaucoma	4.13e-06	0.00054	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NGFR—glaucoma	3.95e-06	0.000517	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CA1—glaucoma	3.95e-06	0.000516	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—TXN—glaucoma	3.9e-06	0.000509	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—TXN—glaucoma	3.86e-06	0.000504	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CTSA—glaucoma	3.83e-06	0.0005	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NTRK1—glaucoma	3.76e-06	0.000491	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	3.68e-06	0.000481	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTT1—glaucoma	3.68e-06	0.000481	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CA2—glaucoma	3.61e-06	0.000472	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.52e-06	0.00046	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.49e-06	0.000456	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CDKN2B—glaucoma	3.46e-06	0.000452	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—EDN1—glaucoma	3.32e-06	0.000434	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—TXN—glaucoma	3.3e-06	0.000431	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTT1—glaucoma	3.21e-06	0.000419	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NGF—glaucoma	3.05e-06	0.000399	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTT1—glaucoma	3.02e-06	0.000395	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.01e-06	0.000393	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTT1—glaucoma	2.99e-06	0.000391	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.98e-06	0.00039	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.97e-06	0.000388	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ABCA1—glaucoma	2.93e-06	0.000383	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP1B1—glaucoma	2.93e-06	0.000383	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—C3—glaucoma	2.9e-06	0.000379	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—APOE—glaucoma	2.7e-06	0.000353	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CAV1—glaucoma	2.68e-06	0.00035	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTT1—glaucoma	2.56e-06	0.000334	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP1B1—glaucoma	2.55e-06	0.000334	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ABCA1—glaucoma	2.55e-06	0.000334	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—FN1—glaucoma	2.55e-06	0.000333	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—TXN—glaucoma	2.55e-06	0.000333	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—BAD—glaucoma	2.52e-06	0.000329	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.41e-06	0.000315	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ABCA1—glaucoma	2.41e-06	0.000314	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP1B1—glaucoma	2.41e-06	0.000314	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ABCA1—glaucoma	2.39e-06	0.000312	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP1B1—glaucoma	2.39e-06	0.000312	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTM1—glaucoma	2.34e-06	0.000306	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—MTHFR—glaucoma	2.07e-06	0.000271	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.06e-06	0.00027	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTM1—glaucoma	2.04e-06	0.000267	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP1B1—glaucoma	2.04e-06	0.000266	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ABCA1—glaucoma	2.04e-06	0.000266	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NOS3—glaucoma	2.02e-06	0.000264	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTT1—glaucoma	1.97e-06	0.000258	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—APOE—glaucoma	1.93e-06	0.000252	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTM1—glaucoma	1.92e-06	0.000251	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CAV1—glaucoma	1.91e-06	0.00025	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTM1—glaucoma	1.91e-06	0.000249	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—MTHFR—glaucoma	1.8e-06	0.000236	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CDKN1B—glaucoma	1.75e-06	0.000229	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—MTHFR—glaucoma	1.7e-06	0.000222	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—MTHFR—glaucoma	1.69e-06	0.00022	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—APOE—glaucoma	1.68e-06	0.000219	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CAV1—glaucoma	1.66e-06	0.000217	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTM1—glaucoma	1.63e-06	0.000213	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MMP9—glaucoma	1.62e-06	0.000212	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—APOE—glaucoma	1.58e-06	0.000207	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ABCA1—glaucoma	1.57e-06	0.000206	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP1B1—glaucoma	1.57e-06	0.000206	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—APOE—glaucoma	1.57e-06	0.000205	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CAV1—glaucoma	1.57e-06	0.000205	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CAV1—glaucoma	1.55e-06	0.000203	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—VEGFA—glaucoma	1.46e-06	0.00019	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—NOS3—glaucoma	1.44e-06	0.000189	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—MTHFR—glaucoma	1.44e-06	0.000188	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—APOE—glaucoma	1.34e-06	0.000175	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CAV1—glaucoma	1.33e-06	0.000174	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PTGS2—glaucoma	1.32e-06	0.000173	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—NOS3—glaucoma	1.26e-06	0.000164	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTM1—glaucoma	1.26e-06	0.000164	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—NOS3—glaucoma	1.19e-06	0.000155	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—NOS3—glaucoma	1.18e-06	0.000154	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PTGS2—glaucoma	1.15e-06	0.00015	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—MTHFR—glaucoma	1.11e-06	0.000145	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TP53—glaucoma	1.1e-06	0.000144	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PTGS2—glaucoma	1.08e-06	0.000142	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PTGS2—glaucoma	1.08e-06	0.00014	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—APOE—glaucoma	1.03e-06	0.000135	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CAV1—glaucoma	1.03e-06	0.000134	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NOS3—glaucoma	1e-06	0.000131	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PTGS2—glaucoma	9.19e-07	0.00012	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NOS3—glaucoma	7.75e-07	0.000101	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PTGS2—glaucoma	7.09e-07	9.26e-05	CbGpPWpGaD
